1 The incidence of antibody formation has been shown to decrease with time (over 3 years)
On October 28, 2024, we closed our IPO, pursuant to which we issued and sold 18.4 million shares of common stock at the public offering price of $18.00 per share, which included 2.4 million shares of our common stock issued and sold on October 30, 2024 to the underwriters pursuant to the full exercise of their option to purchase additional shares of our common stock, at the public offering price of $18.00 per share
However, we are discovering that it does FAR more than that
of this final rule with comment period) is included in the budget neutrality calculations for the CY 2026 OPPS
Schedule: Daily subcutaneous injections for 812 weeks (optionally extended to ~16 weeks), often followed by a short off-cycle
The program is designed for individuals with a BMI of 21 or higher, representing the vast majority of US adults